ヒト成長ホルモン (HGH) の世界市場：産業分析と将来展望
Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook 2018-2022
|出版日||ページ情報||英文 86 Pages
|ヒト成長ホルモン (HGH) の世界市場：産業分析と将来展望 Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook 2018-2022|
|出版日: 2018年03月11日||ページ情報: 英文 86 Pages||
当レポートでは、世界のヒト成長ホルモン (HGH) 市場について調査分析し、疾患・製品の概要や市場力学、全体的な市場規模の推移と見通し、セグメント別・国別の詳細動向、競合情勢、主要企業のプロファイルといった情報を取りまとめてお届けいたします。
Human growth hormone is produced by the pituitary gland and it spurs growth in children and adults. It regulates body fluids, muscle and bone growth and fat metabolism of the body. Growth hormone is important for normal functioning in humans. The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD) and it can be tackled by administering intramuscular or subcutaneous GH injections on daily basis.
In the coming years, this disorder can be treated by various therapeutics which are currently in their final phase of development. This would change the complete market scenario because at present only daily agents are used to treat GHD. The global human growth hormone market is likely to see strong pipeline of drugs with increased research and development activities, which would spur innovation in the market.
The global human growth hormone market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, and long-acting hGH formulations in development. However, the market growth is hindered by high R&D expenditures and expensive drug costs.
The report "Global Human Growth Hormone (Hgh) Market: Industry Analysis & Outlook (2018-2022)" analyzes the development of this market along with the market opportunities. The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global market along with the study of the regional markets.